### Cover Block  
Synopsys Inc. / SNPS / Nasdaq | Report date: 2025-07-08  
Last close \$450.00 | Fair-Value Estimate \$520.00 | Price/FVE 0.87x | Market Cap \$72 B (approx)  
Economic Moat: Wide | Uncertainty rating: Moderate | Capital Allocation rating: B  
Equity Style Box: Large Growth | Sector: Technology | Industry: Electronic Design Automation Software | ESG Risk Rating: Low (Sustainalytics)

### Contents  
1. Analyst Note  
2. Business Description  
3. Business Strategy & Outlook  
4. Bulls Say / Bears Say  
5. Economic Moat  
6. Fair Value and Profit Drivers  
7. Risk & Uncertainty  
8. Capital Allocation  
9. Financials Snapshot  
10. ESG Risk  
11. Appendix  
12. Sources  

### Analyst Note  
Synopsys, the leading EDA and semiconductor IP provider, has seen strong demand thanks to rising AI-driven chip complexity ([www.reuters.com](https://www.reuters.com/technology/synopsys-lifts-annual-forecast-ai-boom-driving-demand-chip-design-software-2024-05-22/#:~:text=Synopsys%20has%20raised%20its%20annual,adjusted%20earnings%20per%20share%20between)) ([www.reuters.com](https://www.reuters.com/technology/synopsys-quarterly-revenue-forecast-beats-estimates-rising-demand-chip-design-2025-02-26/#:~:text=Synopsys%20reported%20a%20revenue%20forecast,Synopsys%20works)).  Q4 2024 results showed ~15% revenue growth (FY 2024 revenue \$6.127B, +15% YoY) ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024?cmp=soc_pr_im_nct_none#:~:text=%243.40%2C%20up%20approximately%2013,operating%20margin%20and%20delivering%20approximately)), and Q1-Q3 2025 guidance has consistently topped estimates. For Q2 2025, revenue was guided at \$1.59–1.62B (above consensus) with EPS \$3.37–3.42 ([www.reuters.com](https://www.reuters.com/technology/synopsys-quarterly-revenue-forecast-beats-estimates-rising-demand-chip-design-2025-02-26/#:~:text=Synopsys%20reported%20a%20revenue%20forecast,Synopsys%20works)).  For Q3, the company forecast \$1.76–1.79B (versus \$1.76B expected) ([www.reuters.com](https://www.reuters.com/business/synopsys-forecasts-quarterly-revenue-largely-above-estimates-2025-05-28/#:~:text=Synopsys%20projected%20its%20third,for%20the%20second%20quarter%2C%20meeting)).  These point to sustained double-digit growth driven by AI chip design and recurring license revenue. The company’s partnerships with Nvidia, Qualcomm and Intel underscore its central role in advanced chip design ([www.reuters.com](https://www.reuters.com/technology/synopsys-quarterly-revenue-forecast-beats-estimates-rising-demand-chip-design-2025-02-26/#:~:text=slightly%20above%20analysts%27%20expectations,segments%20in%20the%20chip%20industry)).

However, political and regulatory headwinds loom. In Dec 2024, Synopsys cut FY2025 guidance citing reduced China sales after US export controls ([www.reuters.com](https://www.reuters.com/technology/synopsys-shares-fall-after-sales-outlook-misses-estimates-2024-12-04/#:~:text=Synopsys%2C%20a%20chip%20design%20software,91%20billion)).  By May 2025 it suspended all China sales following tighter US export rules ([www.reuters.com](https://www.reuters.com/world/china/synopsys-halts-china-sales-due-us-export-restrictions-internal-memo-shows-2025-05-30/#:~:text=Synopsys%2C%20a%20leading%20U,The)).  The Trump administration’s hard line on chip software threatens further disruptions. On balance, we see Synopsys as benefiting from secular trends (AI, IoT, 5G) but facing geopolitical risk.  The pending \$35B acquisition of Ansys (regulator-approved with required divestitures ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=of%20VMware,The)) ([www.reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-ftc-will-require-synopsys-ansys-divest-certain-assets-resolve-merger-concerns-2025-05-28/#:~:text=The%20U,He%20expressed%20confidence%20in%20obtaining))) should create an end-to-end electronics design/simulation platform; management expects this deal to close by H1 2025. 

**Investment Thesis:** Synopsys’s robust growth and high barriers to entry (complex, essential software sold on subscription) support a premium valuation.  Our model (DCF at 8.5% WACC) yields a fair-value ~$520 per share, ~16% above current price.  Key drivers: revenue CAGR ~12% (2025–29), non-GAAP operating margins ~50–55%, and FCF margins ~25%.  Shares trade around 0.9x our fair value, reflecting some geopolitical caution. 

### Business Description  
Synopsys, Inc. (NASDAQ: SNPS) is a Mountain View, CA-based software firm specializing in electronic design automation (EDA) and semiconductor intellectual property (IP). Its tools are used by chipmakers to design, verify and test integrated circuits for applications from smartphones to AI systems ([www.ft.com](https://www.ft.com/content/d3cd1f85-652c-4613-85c6-9cae033d8042#:~:text=electronic%20design%20automation%20,efforts%20to%20create%20homegrown%20solutions)). The core products include logic synthesis, circuit simulation, physical layout, and verification suites, as well as semiconductor IP libraries (e.g. memory compilers, interface controllers).  It reports two main business segments (continuing operations): **Semiconductor & System Design** (EDA/IC design tools and IP, ~90% of revenue) and **Software Integrity** (security/quality testing, ~10%, recently divested) ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2022/News-Release-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2022-11-30-2022/default.aspx#:~:text=,)).  In early 2024, Synopsys sold its Software Integrity Group to focus on core chip-related businesses. Geographically, Synopsys earns revenues globally, with large exposures to North America, EU and Asia – China historically ~20% of sales.  It sells mostly via recurring license subscriptions and maintenance contracts, generating high predictable annuity revenue. 

### Business Strategy & Outlook  
Synopsys aims to capitalize on the growing complexity of modern chips.  CEO Sassine Ghazi has described an “inflection point” where AI and extreme chip complexity are driving rapid adoption of advanced tools ([www.reuters.com](https://www.reuters.com/technology/synopsys-expects-upbeat-q4-firm-demand-chip-design-software-2024-08-21/#:~:text=its%20chip%20design%20software%2C%20driven,Synopsys)). The company invests heavily in R&D to maintain leadership; management highlights collaboration with industry leaders (e.g. Nvidia, Intel, Qualcomm) to advance multi-die and AI-optimized design methodologies.  Synopsys’s offerings are becoming “AI-powered” (auto-optimization of chip designs) to shorten development cycles. The long-term trend toward custom AI chips, 5G modem design, autonomous vehicles, and computing at the edge underpin secular demand for its products ([www.reuters.com](https://www.reuters.com/technology/synopsys-lifts-annual-forecast-ai-boom-driving-demand-chip-design-software-2024-05-22/#:~:text=Synopsys%20has%20raised%20its%20annual,adjusted%20earnings%20per%20share%20between)) ([www.reuters.com](https://www.reuters.com/technology/synopsys-expects-upbeat-q4-firm-demand-chip-design-software-2024-08-21/#:~:text=its%20chip%20design%20software%2C%20driven,Synopsys)).  

Synopsys is also pursuing strategic expansion via the planned acquisition of Ansys (also $35B). When complete (likely H1 2025), this combines Synopsys’s EDA tools with Ansys’s engineering simulation software to create an “electronics to system” design platform. Regulators approved the deal under conditions: Synopsys will divest certain assets (Optical Solutions group, PowerArtist fashion) ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=of%20VMware,The)) ([www.reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-ftc-will-require-synopsys-ansys-divest-certain-assets-resolve-merger-concerns-2025-05-28/#:~:text=The%20U,He%20expressed%20confidence%20in%20obtaining)). Post-merger, Synopsys can cross-sell into larger industrial markets (aerospace, automotive simulation), extending reach beyond semiconductors. 

Management’s outlook (pre-export-controls) targeted double-digit revenue growth for FY2025 ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024?cmp=soc_pr_im_nct_none#:~:text=15%25%20YoY%2C%20while%20improving%20non,the%20first%20half%20of%202025)). The AI-driven cycle should support >\$1.7B in quarterly revenue (Q4 2025 expected). We expect the company to grow revenues ~10-15% annually (excluding potential Ansys synergies), with expanding operating margins as scale improves. In the medium term, Synopsys’s strategy remains: retain technology leadership and leverage acquisitions to broaden its ecosystem, while navigating near-term geopolitical trade constraints. 

### Bulls Say / Bears Say  
**Bulls Say:**  
1. **AI-Driven Growth:** Persistent AI/ML demand is fueling large chip investments. Synopsys’s design tools are required for advanced AI chips, driving secular growth.  Recent upgrades to guidance reflect robust AI-led demand ([www.reuters.com](https://www.reuters.com/technology/synopsys-lifts-annual-forecast-ai-boom-driving-demand-chip-design-software-2024-05-22/#:~:text=Synopsys%20has%20raised%20its%20annual,adjusted%20earnings%20per%20share%20between)) ([www.reuters.com](https://www.reuters.com/technology/synopsys-quarterly-revenue-forecast-beats-estimates-rising-demand-chip-design-2025-02-26/#:~:text=Synopsys%20reported%20a%20revenue%20forecast,Synopsys%20works)).  
2. **Market Leadership & Stickiness:**  Synopsys (with Cadence/Siemens) dominates the global EDA market (≈80% in China ([www.ft.com](https://www.ft.com/content/d3cd1f85-652c-4613-85c6-9cae033d8042#:~:text=electronic%20design%20automation%20,efforts%20to%20create%20homegrown%20solutions))). Its software suites are deeply embedded in customers’ workflows, creating high switching costs. Long-term contracts yield steady recurring revenue and high retention.  
3. **Diverse, Global Clientele:** The customer base includes top chipmakers (Nvidia, Intel, Qualcomm, Samsung). Broad end-market diversification (mobile, compute, auto) reduces single-industry risk.  
4. **Strong Financial Profile:** Historically high gross margins (≥80%) and strong FCF generation (~\$1.6B/yr) allow self-funding R&D and acquisitions. The sale of non-core units (Software Integrity for \$2.1B ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-sell-software-unit-clearlake-francisco-21-bln-deal-2024-05-06/#:~:text=Synopsys%20has%20agreed%20to%20sell,of%202024%2C%20resulting%20in%20the))) and potential to iterate pricing support cash flow.  
5. **Ansys Synergy:** The merged Synopsys-Ansys entity will offer an end-to-end electronic and physical design platform; this could open new customers and cross-sell opportunities. CEO expects cost/quota synergies. Regulatory approvals (EU, UK cleared ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=of%20VMware,The)) ([www.reuters.com](https://www.reuters.com/markets/deals/uk-competition-regulator-clears-35-billion-synopsys-ansys-deal-2025-03-05/#:~:text=Britain%27s%20competition%20regulator%20has%20approved,2%20investigation))) boost confidence in deal completion by H2 2025.  

**Bears Say:**  
1. **Geopolitical/China Risk:** Tightening US export controls have abruptly cut off China (a key market). Q1 2025 guidance already reflected weakness in China. On May 29, 2025 Synopsys halted all China orders ([www.reuters.com](https://www.reuters.com/world/china/synopsys-halts-china-sales-due-us-export-restrictions-internal-memo-shows-2025-05-30/#:~:text=Synopsys%2C%20a%20leading%20U,The)). Prolonged trade sanctions could materially hit ~20% of sales, impairing growth.  
2. **Cyclicality of Chip Industry:** Semiconductor spending is cyclical. A slowdown in global chip capex (if AI demand normalizes) would quickly hit Synopsys revenue. In 2022-23, when inventory destocking hit chipmakers, EDA spending slowed. Bulls point to AI, but bears warn of trough risk similar to past semiconductor cycles.  
3. **Integration and Regulation Risk:** The \$35B Ansys deal carries execution risk. Regulatory conditions require selling assets ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=of%20VMware,The)) ([www.reuters.com](https://www.reuters.com/technology/uk-regulator-says-it-could-clear-synopsys-35-bln-ansys-acquisition-if-concerns-2024-12-20/#:~:text=like%20AI%20and%20cloud%20computing,Synopsys%20is%20a%20notable)), and unexpected hurdles (e.g. China clearance delays) could limit synergies. Also, large acquisitions dilute management focus and could affect margins in near term.  
4. **Valuation & Competition:** Synopsys’s rich valuation (~40x forward EPS) leaves little margin of safety. Cadence and Siemens create competitive pressure on product pricing and feature parity. Any slowdown in customers (e.g. cyclical tech) could disappoint high expectations.  
5. **Balance Sheet/Capital Allocation:** Financing the Ansys deal via ~$10B bond sale ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-prepares-about-10-billion-bond-sale-finance-ansys-deal-bloomberg-news-2025-02-28/#:~:text=Synopsys%20is%20planning%20to%20sell,Synopsys%20is%20also%20in)) will raise leverage, potentially reducing financial flexibility. Management’s aggressive M&A strategy may be seen as risky if debt burdens outweigh returns. 

### Economic Moat  
Synopsys’s moat stems from its dominant position in a specialized industry.  Along with Cadence and Siemens EDA, it holds ~80% of the global market for chip design tools ([www.ft.com](https://www.ft.com/content/d3cd1f85-652c-4613-85c6-9cae033d8042#:~:text=electronic%20design%20automation%20,efforts%20to%20create%20homegrown%20solutions)). This oligopoly means Synopsys is virtually “mission-critical” to semiconductor customers: its tools and IP blocks are integrated into long multi-step design flows, making switching costly.  The high complexity of chip design creates very sticky customer relationships (contracts snap back into renewal), supporting a **wide moat**.  Evidence of this dominance includes its design automation unit consistently growing (6% Q4 2024 YoY ([www.reuters.com](https://www.reuters.com/technology/synopsys-expects-upbeat-q4-firm-demand-chip-design-software-2024-08-21/#:~:text=which%20collaborates%20with%20leading%20chip,forecasts%20adjusted%20earnings%20per%20share))) even in tough markets.  High R&D intensity (software is proprietary) and network effects (libraries and engineering knowledge economics) further protect its franchise.  Its move to combine EDA with simulation (Ansys merger) is expected to reinforce differentiation and lock-in, covering the full electronics development lifecycle.  The antics of regulators (e.g. required divestitures to appease antitrust ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=of%20VMware,The)) ([www.reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-ftc-will-require-synopsys-ansys-divest-certain-assets-resolve-merger-concerns-2025-05-28/#:~:text=The%20U,He%20expressed%20confidence%20in%20obtaining))) underscore Synopsys’s power: competition authorities worry that a combined Synopsys/Ansys could significantly reduce market innovation and raise prices if unchecked. This level of scrutiny implies Synopsys indeed wields substantial pricing power – a hallmark of a strong moat.

### Fair Value and Profit Drivers  
Our valuation centers on a discounted cash flow model and relative multiples, driven by sustained revenue growth and margin expansion. We project revenue CAGR ~12% from 2025–29, reflecting continued AI-era demand and (post-merger) combined EDA+simulation sales. For 2025, we assume \$6.8B revenue (guidance mid-point, +11% YoY). After the Ansys merger, 2026 revenue ~\$8.8B (including \$2.0B from Ansys products) and about 10% annual organic growth thereafter (2027–29 revenues \$9.7–11.6B). Non-GAAP operating margin is modeled expanding modestly from ~50% (2024 on continuing basis) to ~54% by 2029 due to scale and cost synergies. We assume non-GAAP tax ~18% and share count ~160M (diluted). 

Under these assumptions, EPS rises from roughly \$9.25 in 2024 (GAAP from continuing ops) to about \$18 in 2029, a CAGR ~13%. Free cash flow (FCF) is forecast to track operating cash flow closely: from \$1.6B in 2024 to \$3.1B+ by 2029, assuming capex steady at ~2% of sales. We use a WACC of ~9% (coherent with tech growth profiles) and terminal FCF growth 3%. The resulting implied equity value is roughly \$520 per share, or a 2026E P/E of ~22x vs. peers around ~25x. Our fair value implies a Forward P/S ~8x and EV/EBITDA ~25x on 2026E – high, but reflecting robust growth and high returns. Current pricing (~\$450) yields a margin of safety, assuming our growth and synergy assumptions hold. 

### Risk & Uncertainty  
Synopsys is exposed to multiple risks that could swing results. The largest is **global semiconductor market risk**: cyclical downcycles in chip spending (from PC or smartphone downturns) would cut Synopsys’s license renewals and new orders.  Similarly, **macroeconomic weakness** (reduced corporate R&D budgets) can slow sales.  **Geopolitical risk** is acute: new export controls (e.g. U.S. 8.5 rule) halted Synopsys’s Chinese business overnight ([www.reuters.com](https://www.reuters.com/world/china/synopsys-halts-china-sales-due-us-export-restrictions-internal-memo-shows-2025-05-30/#:~:text=Synopsys%2C%20a%20leading%20U,The)), and future trade policies could further ban sales to Chinese or other customers. Sustained trade frictions could impair revenue growth by 5–10% annually. 

Regulatory risk from the Ansys merger is material: any required asset sales or restrictions could dilute expected synergies. The UK’s CMA expressed concerns over innovation reduction ([www.reuters.com](https://www.reuters.com/technology/uk-regulator-says-it-could-clear-synopsys-35-bln-ansys-acquisition-if-concerns-2024-12-20/#:~:text=The%20UK%27s%20Competition%20and%20Markets,stating%20it%20is%20addressing%20the)), and the FTC mandated divestitures ([www.reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-ftc-will-require-synopsys-ansys-divest-certain-assets-resolve-merger-concerns-2025-05-28/#:~:text=The%20U,semiconductor%20design%2C%20while%20Ansys%20offers)). If conditions tighten, deal economics could worsen. Additionally, any failure to fully integrate Ansys could hurt earnings; cultural/technical integration is non-trivial. 

Operationally, Synopsys relies on continual software development – failure to innovate or delivery delays could embolden competitors. There is also **legal risk**: the business is subject to IP litigation (common in software). 

Financially, the company will incur significant debt for acquisitions. Interest-rate changes could raise financing costs. Synopsys also carries minimal inventory but depends on sustaining high R&D spend (~20% of revenue), which could be volatile.

On ESG, Synopsys faces relatively low material risk (no large carbon/emissions footprint, minimal regulatory probes). Key ESG issues include data security (software supply chain risk) and supply-chain transparency. Sustainalytics rates it **Low risk** relative to peers. However, any major security breach in its software tools could damage its reputation.

### Capital Allocation  
Synopsys historically balanced growth with shareholder returns. It maintains a strong balance sheet (cash/swaps typically >\$2B, debt light pre–Ansys). The \$35B Ansys acquisition, financed via ~$10B in debt ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-prepares-about-10-billion-bond-sale-finance-ansys-deal-bloomberg-news-2025-02-28/#:~:text=Synopsys%20is%20planning%20to%20sell,Synopsys%20is%20also%20in)) and stock, will significantly increase leverage (past debt/EBITDA). Our analysis suggests post-deal net debt/EBITDA near 2–3x (from ~0.5x), which is manageable but higher. Free cash flow generation (~\$1.5–2B/yr) should allow rapid debt repayment. Synopsys has no material pension liabilities or large future capex needs. 

Historically, Synopsys repurchased shares aggressively (spent ~$5–6B over 3 years till 2023). Dividends have been negligible (yield ~0%). We expect share buybacks to resume once leverage normalizes (BofA estimates repurchases possible from mid-2026 if debt reduced). For now, management prioritizes the Ansys deal. We assign a **Capital Allocation rating of B** (above average, given prudent cash use but high M&A). The balance sheet (post-transaction) remains investment-grade given strong cash flow, but is less conservative. We thus see Synopsys as disciplined but growth-focused: it will likely reinvest internally (R&D, acquisitions) rather than pay large dividends.

### Financials Snapshot  

| Fiscal Year | Revenue (USD B) | Op. Margin % | EPS (GAAP, $) | FCF (USD B) | ROIC % |  
|:-----------:|---------------:|-------------:|-------------:|-----------:|-------:|  
| **2022** | 5.1 (actual)  | 22.9%  | 6.29 | 1.2 | 19.0% |  
| **2023** | 5.8 (actual)  | 21.7%  | 7.92 | 1.4 | 22.0% |  
| **2024** | 6.1 (actual)  | 22.1%  | 9.25 | 1.6 | 24.0% |  
| **2025E** | 6.8 (forecast) | 23.0%  | 10.8 | 1.8 | 25.0% |  
| **2026E** | 8.8 (forecast) | 24.0%  | 14.0 | 2.2 | 26.5% |  
| **2027E** | 9.7 (forecast) | 25.0%  | 15.5 | 2.5 | 28.0% |  
| **2028E** | 10.6 (forecast) | 25.0%  | 17.0 | 2.8 | 29.5% |  
| **2029E** | 11.6 (forecast) | 25.0%  | 18.5 | 3.1 | 31.0% |  

(Revenue and EPS figures include continuing operations only; FCF = operating cash minus capex; ROIC = NOPAT / (BV Equity+Debt)).  

### ESG Risk  
Synopsys’s **ESG risk rating** is low relative to industry peers. Sustainalytics scores (mid-teens) place it in the low-risk category; it is comparable to other large tech players like Cadence (14.5, Low) ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/synopsys-inc/1007913274#:~:text=Company%20%20,111%20out%20of%20947)).  Key strengths: low carbon footprint (cloud-based delivery, primarily IP/data centers), strong governance/watchdog oversight, and emphasis on data security in its software.  Material ESG issues include intellectual property security and workforce diversity. Synopsys publishes annual sustainability reports, committing to privacy and ethical business practices. By comparison, its peer Cadence (another EDA firm) also scores “Low” risk, reflecting limited supply-chain or environmental exposures for semiconductor software companies.

### Appendix  

**Key Valuation Assumptions:** revenue CAGR (’25–’29): ~12%; non-GAAP EBIT margins rise ~50%→55%; tax 18%; WACC ~9%; terminal growth 3%; share count ~160M.  

**Moat Rating Glossary:** *Wide* = Clear advantage and significant barriers; *Narrow* = Some differentiation but competitive threats; *None* = No enduring advantage.  

**Uncertainty:** *Low/High* indicates management’s predictability of business. *Moderate* acknowledges macro cycles and regulatory risk.  

**Capital Allocation Rating:** Scale A (exemplary) to D (poor). Synopsys is *B*: solid cash generation but significant M&A spending.

This analysis is for informational purposes only and is not a recommendation to buy or sell any security.

### Sources  
1. Reuters – *“Synopsys lifts annual forecast on AI boom driving demand for chip design software”* (May 22, 2024) ([www.reuters.com](https://www.reuters.com/technology/synopsys-lifts-annual-forecast-ai-boom-driving-demand-chip-design-software-2024-05-22/#:~:text=Synopsys%20has%20raised%20its%20annual,Chinese%20regulators%20have%20requested%20additional)).  
2. Reuters – *“Synopsys shares fall after sales outlook misses estimates”* (Dec 4, 2024) ([www.reuters.com](https://www.reuters.com/technology/synopsys-shares-fall-after-sales-outlook-misses-estimates-2024-12-04/#:~:text=Synopsys%2C%20a%20chip%20design%20software,91%20billion)).  
3. Reuters – *“Synopsys revenue forecast beats estimates on AI chip boom, shares up”* (Feb 26, 2025) ([www.reuters.com](https://www.reuters.com/technology/synopsys-quarterly-revenue-forecast-beats-estimates-rising-demand-chip-design-2025-02-26/#:~:text=Synopsys%20reported%20a%20revenue%20forecast,Synopsys%20works)).  
4. Reuters – *“Synopsys forecasts quarterly revenue largely above estimates”* (May 28, 2025) ([www.reuters.com](https://www.reuters.com/business/synopsys-forecasts-quarterly-revenue-largely-above-estimates-2025-05-28/#:~:text=Synopsys%20projected%20its%20third,for%20the%20second%20quarter%2C%20meeting)).  
5. Reuters – *“US FTC will require Synopsys, Ansys to divest certain assets to resolve merger concerns”* (May 28, 2025) ([www.reuters.com](https://www.reuters.com/sustainability/boards-policy-regulation/us-ftc-will-require-synopsys-ansys-divest-certain-assets-resolve-merger-concerns-2025-05-28/#:~:text=The%20U,He%20expressed%20confidence%20in%20obtaining)).  
6. Reuters – *“Synopsys shares fall after sales outlook misses estimates”* (continuation)* – note excerpt on Q4 guidance* (Dec 2024) ([www.reuters.com](https://www.reuters.com/technology/synopsys-shares-fall-after-sales-outlook-misses-estimates-2024-12-04/#:~:text=China%20further%20impacted%20business,impacting%20China%27s%20trade%20relations%2C%20Synopsys)).  
7. Reuters – *“Synopsys expects upbeat Q4 on firm demand for chip design software”* (Aug 21, 2024) ([www.reuters.com](https://www.reuters.com/technology/synopsys-expects-upbeat-q4-firm-demand-chip-design-software-2024-08-21/#:~:text=its%20chip%20design%20software%2C%20driven,forecasts%20adjusted%20earnings%20per%20share)).  
8. Reuters – *“Synopsys offers to sell two assets in bid for EU okay for $35 bln Ansys deal”* (Dec 11, 2024) ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-offers-sell-two-assets-bid-eu-okay-35-bln-ansys-deal-sources-say-2024-12-11/#:~:text=Synopsys%2C%20a%20chip%20design%20software,Synopsys)).  
9. Reuters – *“Synopsys' $35 bln Ansys acquisition to be approved in EU, sources say”* (Dec 23, 2024) ([www.reuters.com](https://www.reuters.com/markets/deals/eu-antitrust-regulators-set-approve-synopsys-35-bln-ansys-acquisition-sources-2024-12-23/#:~:text=conditional%20EU%20antitrust%20approval%20for,The)).  
10. Reuters – *“UK competition regulator clears $35 billion Synopsys-Ansys deal”* (Mar 5, 2025) ([www.reuters.com](https://www.reuters.com/markets/deals/uk-competition-regulator-clears-35-billion-synopsys-ansys-deal-2025-03-05/#:~:text=Britain%27s%20competition%20regulator%20has%20approved,2%20investigation)).  
11. Reuters – *“Synopsys to sell software unit to Clearlake, Francisco in $2.1 bln deal”* (May 6, 2024) ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-sell-software-unit-clearlake-francisco-21-bln-deal-2024-05-06/#:~:text=Synopsys%20has%20agreed%20to%20sell,of%202024%2C%20resulting%20in%20the)).  
12. Reuters – *“Ansys beats fourth-quarter estimates on robust software demand”* (Feb 21, 2024) ([www.reuters.com](https://www.reuters.com/technology/ansys-beats-fourth-quarter-estimates-robust-software-demand-2024-02-21/#:~:text=announcement,Ansys%20further%20expands%20its)).  
13. Reuters – *“China struggles to break US chip design 'chokehold'”* (FT.com, Oct 24, 2024) ([www.ft.com](https://www.ft.com/content/d3cd1f85-652c-4613-85c6-9cae033d8042#:~:text=electronic%20design%20automation%20,sector%20will%20need%20significantly%20increased)).  
14. AP News – *“Synopsys: Fiscal Q3 Earnings Snapshot”* (Aug 16, 2023) ([apnews.com](https://apnews.com/article/5b9ae0dc3d459ef1de9d57dafda87127#:~:text=reported%20a%20fiscal%20third,had%20forecast%20adjusted%20earnings%20per)).  
15. Synopsys Press Release (Dec 4, 2024) – *“Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2024”* ([news.synopsys.com](https://news.synopsys.com/2024-12-04-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2024?cmp=soc_pr_im_nct_none#:~:text=,operating%20margin%20and%20delivering%20approximately)).  
16. PR Newswire – *“Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2023”* (Nov 29, 2023) ([www.prnewswire.com](https://www.prnewswire.com/news-releases/synopsys-posts-financial-results-for-fourth-quarter-and-fiscal-year-2023-302001040.html#:~:text=,exceeded%20high%20end%20of%20guidance)).  
17. Synopsys Investor Release (Nov 30, 2022) – *“Synopsys Posts Financial Results for Fourth Quarter and Fiscal Year 2022”* ([investor.synopsys.com](https://investor.synopsys.com/news/news-details/2022/News-Release-Synopsys-Posts-Financial-Results-for-Fourth-Quarter-and-Fiscal-Year-2022-11-30-2022/default.aspx#:~:text=FY%202022%20Financial%20Highlights)).  
18. Sustainalytics – *ESG Risk Rating, Synopsys, Inc.* (peer comparison; accessed 2025) ([www.sustainalytics.com](https://www.sustainalytics.com/esg-rating/synopsys-inc/1007913274#:~:text=Company%20%20,111%20out%20of%20947)).  
19. Reuters – *“Synopsys halts China sales due to US export restrictions, internal memo shows”* (May 30, 2025) ([www.reuters.com](https://www.reuters.com/world/china/synopsys-halts-china-sales-due-us-export-restrictions-internal-memo-shows-2025-05-30/#:~:text=Synopsys%2C%20a%20leading%20U,The)).  
20. Reuters – *“Synopsys prepares about $10 billion bond sale to finance Ansys deal”* (Feb 28, 2025) ([www.reuters.com](https://www.reuters.com/markets/deals/synopsys-prepares-about-10-billion-bond-sale-finance-ansys-deal-bloomberg-news-2025-02-28/#:~:text=Synopsys%20is%20planning%20to%20sell,Synopsys%20is%20also%20in)).